Literature DB >> 33342667

Re-thinking patient stability for methadone in opioid treatment programs during a global pandemic: Provider perspectives.

Mary A Hatch-Maillette1, K Michelle Peavy2, Judith I Tsui3, Caleb J Banta-Green4, Stephen Woolworth2, Paul Grekin5.   

Abstract

COVID-19 necessitated rapid changes in methadone take-home policies in opioid treatment programs (OTPs); these changes markedly contrast with existing, long-standing federal mandates on OTP rules about take-home methadone. OTP providers describe how these changes have affected clinical decision-making, equity in patient care, and workflow. We also discuss implications for medical ethics and patient autonomy. We provide suggestions for future research that will examine the impact of COVID-19 on OTP treatment and its patients, as well as the effect of making methadone take-home polices patient centered, all of which may foreshadow larger changes in the ways OTPs deliver their services.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Methadone; OTPs; Opioid treatment programs; Take-home dosing

Mesh：

Substances：

Year:  2020        PMID： 33342667      PMCID： PMC8005420          DOI： 10.1016/j.jsat.2020.108223

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN： 0740-5472


  10 in total

1.  Comparing Canadian and United States opioid agonist therapy policies.

Authors:  Kelsey C Priest; Lauren Gorfinkel; Jan Klimas; Andrea A Jones; Nadia Fairbairn; Dennis McCarty
Journal:  Int J Drug Policy       Date:  2019-02-11

Review 2.  Personalizing the Treatment of Substance Use Disorders.

Authors:  Nora D Volkow
Journal:  Am J Psychiatry       Date:  2020-02-01       Impact factor: 18.112

3.  Methadone maintenance in primary care: a randomized controlled trial.

Authors:  D A Fiellin; P G O'Connor; M Chawarski; J P Pakes; M V Pantalon; R S Schottenfeld
Journal:  JAMA       Date:  2001-10-10       Impact factor: 56.272

Review 4.  Medical ethics: four principles plus attention to scope.

Authors:  R Gillon
Journal:  BMJ       Date:  1994-07-16

5.  Methadone medical maintenance in primary care. An implementation evaluation.

Authors:  Joseph O Merrill; T Ron Jackson; Beryl A Schulman; Andrew J Saxon; Asaad Awan; Sonja Kapitan; Molly Carney; Lyndia C Brumback; Dennis Donovan
Journal:  J Gen Intern Med       Date:  2005-04       Impact factor: 5.128

6.  Methadone maintenance treatment: the balance between life-saving treatment and fatal poisonings.

Authors:  A Fugelstad; M Stenbacka; A Leifman; M Nylander; I Thiblin
Journal:  Addiction       Date:  2007-03       Impact factor: 6.526

7.  Patient-centered methadone treatment: a randomized clinical trial.

Authors:  Robert P Schwartz; Sharon M Kelly; Shannon G Mitchell; Jan Gryczynski; Kevin E O'Grady; Devang Gandhi; Yngvild Olsen; Jerome H Jaffe
Journal:  Addiction       Date:  2016-11-10       Impact factor: 6.526

Review 8.  Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Authors:  Luis Sordo; Gregorio Barrio; Maria J Bravo; B Iciar Indave; Louisa Degenhardt; Lucas Wiessing; Marica Ferri; Roberto Pastor-Barriuso
Journal:  BMJ       Date:  2017-04-26

9.  Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program.

Authors:  K Michelle Peavy; James Darnton; Paul Grekin; Monica Russo; Caleb J Banta Green; Joseph O Merrill; Charissa Fotinos; Steve Woolworth; Sean Soth; Judith I Tsui
Journal:  AIDS Behav       Date:  2020-09

10.  Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England.

Authors:  Matthias Pierce; Sheila M Bird; Matthew Hickman; John Marsden; Graham Dunn; Andrew Jones; Tim Millar
Journal:  Addiction       Date:  2015-11-25       Impact factor: 6.526
  10 in total
  3 in total

1.  COVID-19-related policy changes for methadone take-home dosing: A multistate survey of opioid treatment program leadership.

Authors:  Ximena A Levander; Jarratt D Pytell; Kenneth B Stoller; P Todd Korthuis; Geetanjali Chander
Journal:  Subst Abus       Date:  2021-10-19       Impact factor: 3.716

2.  "It's like 'liquid handcuffs": The effects of take-home dosing policies on Methadone Maintenance Treatment (MMT) patients' lives.

Authors:  David Frank; Pedro Mateu-Gelabert; David C Perlman; Suzan M Walters; Laura Curran; Honoria Guarino
Journal:  Harm Reduct J       Date:  2021-08-14

3.  Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis.

Authors:  Ximena A Levander; Kim A Hoffman; John W McIlveen; Dennis McCarty; Javier Ponce Terashima; P Todd Korthuis
Journal:  Addict Sci Clin Pract       Date:  2021-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.